A minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain

Ended Project Grant Awarded Last action

Award ID
R43EB031671
Recipient
Awarding agency
Obligated
$256,046

Award facts

Completion date
Place of performance
Texas, USA

Award details come from USAspending.gov.

Description

Abstract
Teliatry proposes to build world's smallest (0.75CC), most cost-effective, minimally invasive single incision surgery, 16-channel, rechargeable, spinal cord stimulator (SCS) system to bring proven SCS therapy to mainstream chronic pain management. IT eliminates the need for creating an IPG pocket, eliminates tunneling, exploits a novel shape memory polymer (SMP)lead that can be inserted percutaneously without altering current surgical technique but "unrolls" into a paddle in epidural space. IT also softens to conform to the epidural space mitigating issues with lead migration and lead breakage. The electrodes on the paddle are high surface area, low polarization, fractal topology titanium nitride (tin) that further reduce the energy required by up to 70% of percutaneous cylindrical electrodes. This in turn reduces the battery capacity requirement and allows US to exploit a miniature, multi-stack solid state battery (SSB) architecture that is manufactured at wafer level on a glass substrate. IT is intrinsically safe, MRI compatible and has extremely high charge & discharge rate (20C) and high recharge cycle (2000+) equating to 10+ years lifetime. This further eliminates the need for repeat battery replacement surgery every few years. In recent times, miniature, battery less SCS systems have entered the market but they limit patients comfort and lifestyle by forcing external power & communications module(PCM) to be worn at all times and also have issues with alignment of the PCM with the implant for proper power coupling. Our proposed system is even smaller than these batteries less system and with an average recharge time of

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Original award $256,046

Quick answers

Who received award R43EB031671?

R43EB031671 was awarded to Teliatry Inc. by National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) on March 26, 2021.

How much is award R43EB031671 worth?

$256,046 has been obligated on R43EB031671.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award